Scott Gottlieb, MD, as the 23rd commissioner of the U.S. Food and Drug Administration, Scott Gottlieb, MD, focused on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. Dr. Gottlieb is an aggressive advocate for advancing the health of patients, promoting healthcare access and driving innovation. The agency’s historic and prolific advances in new policy distinguished his tenure as the FDA’s commissioner, in addition to a record-setting number of approvals of novel drugs, medical devices and generic medicines.
Under his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs and digital health devices. The agency implemented new reforms to standardize drug reviews and make historic improvements of post-market data collection and the use of real-world evidence. They promoted policies to reduce death and disease from tobacco, improve food innovation and safety, and aggressively confront addiction crises.
Previously, Dr. Gottlieb served as the FDA’s deputy commissioner for Medical and Scientific Affairs and, before that, as a senior adviser to the administrator of the Centers for Medicare and Medicaid Services. A healthcare futurist, he has worked as a venture capitalist and founder and board member to companies that have developed new medicines and advanced the delivery of healthcare.
Dr. Gottlieb is widely published in leading medical journals and periodicals, including The Wall StreetJournal, The New York Times and The Washington Post, and appears regularly as a guest commentator on CNBC. Fortune magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and 2019. Modern Healthcare named Dr. Gottlieb as one of the “Most Influential Physician Executive and Leaders” in its annual survey of 50 physician executives, and Time magazine named him one of its “50 People Transforming Healthcare in 2018.” Dr. Gottlieb was a practicing hospitalist and a clinical assistant professor at the New York University School of Medicine. He is a member of the National Academy of Medicine and a Resident Fellow at the American Enterprise Institute in Washington, DC.
Thursday, Oct 10, 1:30 pm: Keynote Address (CE)